ES8201142A1 - Procedimiento para la preparacion de 2-acilaminometil-1h-2,3-dihidro-1,4-benzodiazepinas - Google Patents

Procedimiento para la preparacion de 2-acilaminometil-1h-2,3-dihidro-1,4-benzodiazepinas

Info

Publication number
ES8201142A1
ES8201142A1 ES498071A ES498071A ES8201142A1 ES 8201142 A1 ES8201142 A1 ES 8201142A1 ES 498071 A ES498071 A ES 498071A ES 498071 A ES498071 A ES 498071A ES 8201142 A1 ES8201142 A1 ES 8201142A1
Authority
ES
Spain
Prior art keywords
compounds
hydrogen
formula
alkyl
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES498071A
Other languages
English (en)
Other versions
ES498071A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Publication of ES498071A0 publication Critical patent/ES498071A0/es
Publication of ES8201142A1 publication Critical patent/ES8201142A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 2-ACILAMINOMETIL-1H-2,3-DIHIDRO-1,4-BENZODIAZEPINAS, DE FORMULA (I), DONDE R1 ES HIDROGENO, UN GRUPO ALCOHILO O ALQUENILO DE BAJO PESO MOLECULAR O UN GRUPO CICLOPROPILMETILO; R2 ES HIDROGENO, UN GRUPO ALQUENILO DE BAJO PESO MOLECULAR; R3 ES UN RADICAL DE FORMULA (II); A Y B ESTAN, INDEPENDIENTEMENTE UNO DE OTRO, NO SUSTITUIDOS CON UNO A TRES SUSTITUYENTES ELEGIDOS DEL GRUPO FORMADO POR HALOGENO, ALCOHILTIO, ALCOXI, ALCOHILO, HIDROXI, NITRO Y TRIFLUOROMETILO, O A Y B SON RADICALES FENILO, ASI COMO SUS ISOMEROS OPTICAMENTE ACTIVOS Y SUS SALES DE ADICION DE ACIDO. CONSISTE EN HACER REACCIONAR UNA AMINA DE FORMULA (III), DONDE A,B,R1 Y R2 TIENEN LOS SIGNIFICADOS YA INDICADOS.
ES498071A 1979-12-24 1980-12-23 Procedimiento para la preparacion de 2-acilaminometil-1h-2,3-dihidro-1,4-benzodiazepinas Expired ES8201142A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792952279 DE2952279A1 (de) 1979-12-24 1979-12-24 Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES498071A0 ES498071A0 (es) 1981-12-01
ES8201142A1 true ES8201142A1 (es) 1981-12-01

Family

ID=6089628

Family Applications (2)

Application Number Title Priority Date Filing Date
ES498071A Expired ES8201142A1 (es) 1979-12-24 1980-12-23 Procedimiento para la preparacion de 2-acilaminometil-1h-2,3-dihidro-1,4-benzodiazepinas
ES498072A Granted ES498072A0 (es) 1979-12-24 1980-12-23 Procedimiento para la preparacion de 2-azidometil-5-fenil-1h-2,3-dihidro-1,4-benzodiazepinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES498072A Granted ES498072A0 (es) 1979-12-24 1980-12-23 Procedimiento para la preparacion de 2-azidometil-5-fenil-1h-2,3-dihidro-1,4-benzodiazepinas

Country Status (21)

Country Link
US (2) US4325957A (es)
EP (1) EP0031080B1 (es)
JP (1) JPS5699477A (es)
AU (1) AU542701B2 (es)
CA (1) CA1169425A (es)
DD (2) DD200274A5 (es)
DE (3) DE2952279A1 (es)
DK (1) DK548080A (es)
ES (2) ES8201142A1 (es)
FI (1) FI68050C (es)
GR (1) GR73080B (es)
HU (1) HU185398B (es)
IE (1) IE50580B1 (es)
IL (1) IL61692A (es)
NO (1) NO154883C (es)
NZ (1) NZ195872A (es)
PH (1) PH17189A (es)
PT (2) PT72279B (es)
SU (1) SU1253430A3 (es)
YU (1) YU324780A (es)
ZA (1) ZA807704B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021107A1 (de) * 1980-06-04 1981-12-17 Hoechst Ag, 6000 Frankfurt Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
EP0170024A3 (en) * 1984-06-26 1990-01-31 Merck & Co. Inc. Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
JPH01314666A (ja) * 1988-06-15 1989-12-19 Kayaba Ind Co Ltd パワーステアリング装置の操舵力制御装置
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
JPH0546660U (ja) * 1991-12-03 1993-06-22 カヤバ工業株式会社 パワーステアリング装置
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
WO2001016276A1 (en) 1999-08-27 2001-03-08 The Procter & Gamble Company Stability enhancing formulation components, compositions and laundry methods employing same
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
JP2003510251A (ja) * 1999-08-27 2003-03-18 ザ、プロクター、エンド、ギャンブル、カンパニー ブリーチ増強成分、組成物および洗濯方法
MXPA02002129A (es) * 1999-08-27 2002-09-18 Procter & Gamble Componentes de formulacion de accion rapida, composiciones y metodos para lavanderia que los emplean.
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
CN113149914A (zh) * 2021-01-15 2021-07-23 福安药业集团重庆礼邦药物开发有限公司 一种咪达唑仑中间体脱氟杂质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681340A (en) * 1968-02-12 1972-08-01 Herman Robert Rodriguez 1,3-benzodiazepines
US3738999A (en) * 1970-05-28 1973-06-12 Squibb & Sons Inc 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
DE2353187A1 (de) * 1973-05-02 1974-11-14 Kali Chemie Ag Neue benzodiazepinderivate
US3925358A (en) * 1973-07-27 1975-12-09 Hoffmann La Roche 1-Lower alkyl-2-substituted-1,4-benzodiazepines
US3947475A (en) * 1975-04-28 1976-03-30 Stauffer Chemical Company 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
US4087421A (en) * 1976-04-19 1978-05-02 American Cyanamid Company Substituted benzodiazepines and method of use

Also Published As

Publication number Publication date
EP0031080B1 (de) 1983-09-21
GR73080B (es) 1984-01-31
US4382030A (en) 1983-05-03
YU324780A (en) 1983-12-31
AU6566480A (en) 1981-07-02
NO154883B (no) 1986-09-29
FI68050B (fi) 1985-03-29
JPS6332072B2 (es) 1988-06-28
EP0031080A1 (de) 1981-07-01
IE802531L (en) 1981-06-24
PT72278B (en) 1981-11-06
ES8201143A1 (es) 1981-12-01
PH17189A (en) 1984-06-14
IL61692A (en) 1984-08-31
IL61692A0 (en) 1981-01-30
NO803935L (no) 1981-06-25
IE50580B1 (en) 1986-05-14
DD200274A5 (de) 1983-04-06
DK548080A (da) 1981-07-23
ZA807704B (en) 1981-11-25
JPS5699477A (en) 1981-08-10
NZ195872A (en) 1983-06-17
PT72279B (en) 1981-11-06
DE3070798D1 (en) 1985-07-25
DD155988A5 (de) 1982-07-21
DE2952279A1 (de) 1981-06-25
NO154883C (no) 1987-01-07
PT72279A (en) 1981-01-01
ES498072A0 (es) 1981-12-01
FI803988L (fi) 1981-06-25
AU542701B2 (en) 1985-03-07
SU1253430A3 (ru) 1986-08-23
ES498071A0 (es) 1981-12-01
DE3064983D1 (en) 1983-10-27
HU185398B (en) 1985-01-28
PT72278A (en) 1981-01-01
US4325957A (en) 1982-04-20
CA1169425A (en) 1984-06-19
FI68050C (fi) 1985-07-10

Similar Documents

Publication Publication Date Title
ES8201143A1 (es) Procedimiento para la preparacion de 2-azidometil-5-fenil-1h-2,3-dihidro-1,4-benzodiazepinas
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
AU6747687A (en) New derivatives of decahydroquinoline,their preparation process, the preparation intermediates, their use as medicaments and the compositions containing them
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
IL113044A0 (en) N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them
ES475173A1 (es) Procedimiento para la fabricacion de quinazolinas.
ES8703870A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
ATE22065T1 (de) Alkan- und alkenderivate und ihre herstellung und verwendung.
AU7529487A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
SE8501988L (sv) Iminotiazolidinderivat
PT76335A (de) Neue basisch substituierte 4-phenyl-4,5,6,7-tetrahydro-thieno-<2,3-c>pyridine verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL61560A0 (en) 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
ES8609207A1 (es) Procedimiento para la preparacion de derivados de feniletilamina.
ES8300721A1 (es) "procedimiento para la preparacion de 2-fenilacilaminometil-1h-2,3-dihidro-1,4-benzodiazepinas".
ES2010855A6 (es) Procedimiento de preparacion de derivados de dioxazocina.
ES8602797A1 (es) Procedimiento para preparar 11-piperazinil-5h-imidazo(2, 1-c) (1, 4) benzodiazepinas
ES8202544A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas -(2) sustituidas
SE8702527D0 (sv) Metylenderivat av androst-4-en-3,17-dioner och forfarande for deras framstellning
SE7807038L (sv) Substituerade 1-tienyl och furyl-2,3,4,5 tetrahydro-1h-3 bensazepinforeningar
IT1304656B1 (it) Derivati dell'acido retinoico per uso medicinale e relativometodo di preparazione.
JPS5649362A (en) Thiocarbostyril derivative